Pharmaceutical Pollution from Human Use and the Polluter Pays Principle.

Area of Science:

• Environmental Science
• Public Health Policy
• Environmental Ethics

Background:

• Human pharmaceutical consumption results in environmental residue release via excreta, posing ecological and public health concerns.
• Current policy debates consider the Polluter Pays Principle (PPP) for distributing management responsibilities and costs.
• Existing ethical and practical challenges limit the sole application of PPP in pharmaceutical pollution management.

Purpose of the Study:

• To evaluate the applicability of the Polluter Pays Principle (PPP) for pharmaceutical pollution.
• To propose an alternative or hybrid policy framework for managing pharmaceutical residues in the environment.
• To identify effective strategies for mitigating pharmaceutical pollution from human use.

Main Methods:

• Ethical and practical analysis of the Polluter Pays Principle (PPP) in the context of pharmaceutical pollution.
• Development of a hybrid policy framework integrating PPP with the Ability to Pay Principle (APP).
• Review of potential policy interventions, including wastewater treatment improvements.

Main Results:

• The Polluter Pays Principle (PPP) presents significant limitations in identifying responsible parties and assigning accountability for pharmaceutical pollution.
• A hybrid framework combining PPP with the Ability to Pay Principle (APP) offers a more robust approach.
• Improving wastewater treatment and cost distribution among consumers or taxpayers are identified as promising management strategies.

Conclusions:

• Sole reliance on the Polluter Pays Principle (PPP) is insufficient for addressing pharmaceutical pollution from human consumption.
• A hybrid approach, integrating the Polluter Pays Principle (PPP) with the Ability to Pay Principle (APP), is recommended for equitable and effective risk management.
• Further empirical research is necessary to inform sound policy development for pharmaceutical pollution control.